Brief: NeuroVive Pharmaceutical Q1 Pre-Tax Loss Narrows To SEK 13.1 Million

Abliva AB

22/05/2018 07:42

May 22 (Reuters) - NEUROVIVE PHARMACEUTICAL AB  NVP.ST :
    * Q1 NET REVENUE SEK 0 VERSUS SEK 27,000 YEAR AGO
    * Q1 PRE-TAX LOSS SEK 13.1 MILLION VERSUS LOSS SEK 21.4
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkrdBCK6 
Further company coverage:  NVP.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))